Trial intelligence / Profile preview

Salivary cortisol assessment of preoperative anxiety in children with video distraction or midazolam

RBR-6kzpwykPhase 4Not yet recruiting

Sponsor
IMIP
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of midazolam in anxiety disorder, sponsored by IMIP. Planned start Oct 2024; status: not yet recruiting.

02

Drugs

midazolam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on RBR-6kzpwyk.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6kzpwyk.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call